Status:
COMPLETED
Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
Astellas Pharma US, Inc.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
We are studying the affect of caffeine on the sensitivity of detecting coronary artery disease (blockages in the blood flow to the heart) with adenosine tracer scans. Adenosine is a drug used routinel...
Eligibility Criteria
Inclusion
- Patients who have already completed rest/stress 99mTc sestamibi or 99mTc tetrofosmin imaging will be given a form describing this protocol and asked to volunteer for the additional scan
Exclusion
- history of asthma, bronchospastic COPD, or renal failure
Key Trial Info
Start Date :
June 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2004
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00205166
Start Date
June 1 1999
End Date
December 1 2004
Last Update
October 29 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53792